UAB "Valentis Pharma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| -9,675 |
| -685 |
| -352,499 |
| -367,614 |
| -26,017 |
| 100.00 |
| 3,799.63 |
| -283,017 |
| 621,226 |
| 83,730 |
| 254,479 |
| 2023 |
|---|
| 0 |
| 0 |
| -82,689 |
| -82,689 |
| -12,089 |
| - |
| - |
| 234,294 |
| 2,635 |
| 83,730 |
| 153,199 |
| 2024 |
|---|
| 0 |
| 0 |
| -35,777 |
| -35,777 |
| -8,922 |
| - |
| - |
| 198,516 |
| 2,518 |
| 83,730 |
| 117,304 |
Register and
explore Okredo data| 2024 |
|---|
| 0 |
| 0 |
| -35,777 |
| -35,777 |
| -8,922 |
| - |
| - |
| 198,516 |
| 2,518 |
| 83,730 |
| 117,304 |
Register and
explore Okredo data2024
Turnover (€)
0 €
- *
Sales per employee (€)
0 €- *
Profit before tax (€)
-35,777 €
57 % *
Net Profit (€)
-35,777 €57 % *
Profit per employee (€)
-8,922 €26 % *
Total profitability (%)
-Net profitability (%)
-Equity (€)
198,516 €
-15 % *
Amounts Payable And Liabilities (€)
2,518 €
-4 % *
Non-current Assets (€)
83,730 €0 % *
CurrentAssets (€)
117,304 €-23 % *